Resumen

SILVA PUPO, Milena; GONZALEZ MOYA, Israel Alejandro; VALENCIANO GARCIA, Yilena  y  GONZALEZ CEDENO, Mileidys. Evolution of complex lesions in the diabetic foot using Heberprot-P®. AMC [online]. 2015, vol.19, n.4, pp.357-365. ISSN 1025-0255.

Background: diabetic foot is one of the most alarming chronic complications of diabetes mellitus because of the risk of amputations of the inferior limbs and the psycho-social damage that entails. There are areas prone to unfavourable lesions like the calcaneus region and the plantar area. Objective: to evaluate the evolution of complex lesions in diabetic foot with the use of Heberprot-P. Methods: a descriptive, longitudinal, retrospective study was made to the patients admitted in the Manuel Ascunce Domenech Provincial Hospital with the diagnosis of diabetic foot between June 2013 and April 2014. The patients presented complex lesions. The universe was composed of 48 patients. The non-probabilistic sample included 36 patients who matched the established inclusion and exclusion criteria. The information obtained was processed by means of the statistical program SPSS-11.5 for Windows and the descriptive statistics with distribution of frequencies and percents. The results of the study were exposed in tables. Results: it was found that female was the most affected sex with a higher incidence in the age group 56-65. The etiological diagnosis of diabetic foot was neuroinfectious. The most affected inferior limb was the right foot. Wagner classification of level 3 included most of the cases. The research had a successful outcome with 33 closed cases. Conclusions: the purpose of handling with diabetic foot ulcers is to prevent amputation and keeping a good quality of life. Heberprot-P is a product that modifies the amputation criteria and is a valuable option for the patient and the doctor.

Palabras clave : DIABETIC FOOT [therapy]; ULCER; QUALITY OF LIFE; DRUG EVALUATION; EPIDEMIOLOGY, DESCRIPTIVE.

        · resumen en Español     · texto en Español     · Español ( pdf )